Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) expedites neutrophil recovery in cancer patients receiving chemotherapy with or without autologous bone marrow transplant (ABMT). The limited cost analyses available in patients undergoing ABMT support a cost reduction of about 2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 1994-01, Vol.5 (1), p.56-77
Hauptverfasser:	Goa, K L, Bryson, H M
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - economics Anti-Bacterial Agents - therapeutic use Bone Marrow Transplantation - adverse effects Costs and Cost Analysis Drug-Related Side Effects and Adverse Reactions Economics, Pharmaceutical Formularies as Topic Granulocyte Colony-Stimulating Factor - economics Granulocyte Colony-Stimulating Factor - therapeutic use Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects Granulocyte-Macrophage Colony-Stimulating Factor - economics Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use Humans Neoplasms - drug therapy Neutropenia - chemically induced Neutropenia - drug therapy Neutropenia - economics Neutropenia - epidemiology Transplantation, Autologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!